Pulse nav.journalClub Debates ativos Tendências Explorar Pesquisadores

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Início Explorar nav.journalClub Tendências

⌘+K

© Synapse Social LLC, 2026

Política de privacidade

October 28, 1999Open Access

Use of the Selective Oral Neuraminidase Inhibitor Oseltamivir to Prevent Influenza

Key Points

Key points are not available for this paper at this time.

Abstract

Oseltamivir administered daily for six weeks by the oral route is safe and effective for the prevention of influenza.

Read Full Paperexternally

Perguntar à IA

Like

Bookmark

Share

View Full Paper

Perguntar à IA

Like

Bookmark

Share

View Full Paper

Cite This Study

Hayden et al. (Thu,) studied this question.

synapsesocial.com/papers/69d91df1da3af5b1d0835ab3 https://doi.org/https://doi.org/10.1056/nejm199910283411802

Use of the Selective Oral Neuraminidase Inhibitor Oseltamivir to Prevent Influenza | Synapse

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Resampling-Based Multiple Testing: Examples and Methods for p-Value Adjustment.1994 · 1,733 citations
2Sequential Outbreak of Influenza A and B in a Nursing Home: Efficacy of Vaccine and Amantadine1996 · 52 citations
3Characterization of an Avian Influenza A (H5N1) Virus Isolated from a Child with a Fatal Respiratory Illness1998 · 1,358 citations
4Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-α-d-N-acetylneuraminate) substrate1979 · 824 citations
5In-vitro antimicrobial activity of HMR 3004 (RU 64004) against erythromycin A-sensitive and -resistant Corynebacterium spp. isolated from clinical specimens1998 · 80 citations